1 result(s) displayed (1 - 1 of 1):
After about five months on the job, Sanofi-Aventis SA (NYSE:SNY) chief executive Chris Viehbacher is making his presence felt as the company reports profits are up about 16% and confirmed 2009 guidance.Viehbacher, on the hunt for acquisitions, cut 14 drugs in development from its pipeline of 65 -- including four...
Posted on April 29, 2009 2:53 PM
Movable Type search results powered by Fast Search